They plan to sell their products to the Asian market first.
We have the term “medicinal glasses” to refer to the glasses used for people with eye diseases, but in fact, this “medicine” does not cure the disease. It is not known if the Japanese have this term, we only know that the Kubota company named for its myopic glasses as Kubota Glasses – Kubota glasses or smart glass – smart glass.
The device, still in the test phase, will use the lens to project an image into the retina of the wearer’s eye, correcting light reflection aberrations that cause myopia. Wearing Kubota glasses for 60 to 90 minutes a day will cure illnesses, the company estimates.
Kubota Pharmaceuticals doesn’t say exactly how smart glasses work. Currently, they are trying to figure out how long the treatment will last, how many days the treatment will take, whether the patient will need to use smart glasses for life.
According to the survey, we Asians are very short-sighted. The Kubota Business Survey showed that by the age of 20, the rate of myopia reached 96% in Korea, 95% in Japan, 85% in Taiwan and 82% in Singapore.
“We plan to sell our products first in Asia, where the percentage of myopia is high,” said Ryo Kubota, president of the company. The Tokyo-based company will market the drug in Taiwan, Singapore, Thailand and Malaysia in the second half of 2021. They still plan to sell it in stores or do business online.
After determining the effectiveness of the glasses using a computer simulation program, the Kubota Company began human testing in July of last year. They are also developing a type of contact lens for myopia. If this product is successful, it will be the most effective non-invasive myopia treatment we have, and it will bring brilliant eyes to millions of people.
